Glantz retired from the University of California San Francisco faculty in 2020 after 45 years on the faculty and founding the UCSF Center for Tobacco Control Research and Education. Learn more at https://profglantz.com/about. .. more
Glantz retired from the University of California San Francisco faculty in 2020 after 45 years on the faculty and founding the UCSF Center for Tobacco Control Research and Education. Learn more at https://profglantz.com/about.
Stanton Arnold Glantz is an American professor, author, and tobacco control activist. Glantz is a faculty member at the University of California, San Francisco (UCSF) School of Medicine, where he is a Professor of Medicine (retired) in the Division of Cardiology, the American Legacy Foundation Distinguished Professor of Tobacco Control, and former director of the Center for Tobacco Control Research and Education. Glantz's research focused on the health effects of tobacco smoking. .. more
Reposted by Mike Daube
My colleagues at UCSF and Stanford have submitted this…
NOTE: No one in history EVER "quit by accident with an NRT or varenicline.
Reposted by Stanton A. Glantz
NOTE: No one in history EVER "quit by accident with an NRT or varenicline.
As you know, dual use is:
- smokers who sometimes try a vape
- smokers "on the journey to quit"
- vapers who sometimes have a cig
Presented data a year after the quit attempt. More smokers given ecigs were dual users than quitters. The journey leaves them worse off.
Reposted by Stanton A. Glantz
As you know, dual use is:
- smokers who sometimes try a vape
- smokers "on the journey to quit"
- vapers who sometimes have a cig
One concern about giving smokers e-cigarettes as a smoking cessation aid is that doing so instantly converts them into dual users (smoking both cigarettes and e-cigarettes), which adds…
@chancethegardener.bsky.social @aliveadvocacy.bsky.social @ianamossyd.bsky.social @igas2.bsky.social @publichealthaus.bsky.social @crikey.com.au @theracp.bsky.social @jmenezes.bsky.social @jamomartin.bsky.social
Reposted by Stanton A. Glantz
He showed that "The use of NRT bought over the counter was associated with a lower odds of abstinence (odds ratio, 0.68; 95% CI, 0.49-0.94)." Prescription NRT + counseling works. You guys are ignoring that important distinction. www.mayoclinicproceedings.org/article/S002...
Reposted by Stanton A. Glantz
This blog focuses on tobacco and cannabis and public health, so I have refrained from commenting on broader public health issues. But, I am making an exception to disseminate the National Academy of…
California has enacted the first law, AB455, that requires sellers of single-family homes to disclose in writing any known indoor smoking, vaping, or thirdhand smoke contamination to prospective buyers. It also also directs the…
In the 1990s, good vs. evil was clear. Back then, I focused on HIV, TB, malaria, dengue & child health, and avoided tobacco control because its go-to interventions were stigma, coercion and harm exaggerations.
Reposted by Stanton A. Glantz
In the 1990s, good vs. evil was clear. Back then, I focused on HIV, TB, malaria, dengue & child health, and avoided tobacco control because its go-to interventions were stigma, coercion and harm exaggerations.
At least you now admit that you are promoting an assumption.
Reposted by Stanton A. Glantz
You seem to WANT dual use to be the most common outcome. But you know it's:
(a) smokers on the journey to quit
(b) smokers who sometimes vape
(c) vapers who sometimes still have a cig
But Americans who smoke are 20 times more likely to TRY to quit with a nicotine vape than with Varenicline.
link.springer.com/article/10.1...
Last year we published "Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes" that showed that some disease risks of e-cigarettes are indistinguishable from cigarettes and for others they on only…
Reposted by Stanton A. Glantz
But Americans who smoke are 20 times more likely to TRY to quit with a nicotine vape than with Varenicline.
link.springer.com/article/10.1...
Reposted by Stanton A. Glantz
You seem to WANT dual use to be the most common outcome. But you know it's:
(a) smokers on the journey to quit
(b) smokers who sometimes vape
(c) vapers who sometimes still have a cig
"Effective" = "efficacy" + USE
Efficacy: www.cochranelibrary.com/cdsr/doi/10....
Use: link.springer.com/article/10.1...
Reposted by Stanton A. Glantz
"Effective" = "efficacy" + USE
Efficacy: www.cochranelibrary.com/cdsr/doi/10....
Use: link.springer.com/article/10.1...